SISVEL-INTERNATIONAL
19.7.2022 09:32:08 CEST | Business Wire | Press release
Sisvel International S.A. (“Sisvel”) today announced the launch of a patent pool on Wi-Fi 6 technology. The initial members of this pool will be Huawei, Mediatek, Philips, SK Telecom and Wilus. Huawei and Philips are also the first licensees of the pool. Along with the Wi-Fi 6 pool, Sisvel also debuted a new structured payment plan — the Licensing Incentive Framework for Technologies (LIFT).
Even before the official publication of the standard by IEEE, Wi-Fi 6 (802.11ax) has been pervasive in the market. Increased average throughput per user -the standard itself talks about a fourfold increase- and increased number of concurrent users in high density scenarios (offices, campuses, airports, stadiums, etc.) are among the main benefits of Wi-Fi 6 when compared to Wi-Fi 5. Wi-Fi 6 has brought wireless connectivity to a whole new level. Additional information about the technological advances of Wi-Fi 6 and how it enhances and enables existing and new applications can be found on Sisvel’s blog [https://www.sisvel.com/blog/wireless-communications ].
Sisvel is committed to create licensing solutions that work for both innovators and implementers. To facilitate early adoption of licenses, Sisvel created a new royalty scheme, the Licensing Incentive Framework for Technologies (or LIFT), which will be available to licensees of this new pool. “LIFT is the result of a two-year effort, specifically built to address the disadvantage that sometimes early licensees can feel and the “I don’t want to be the first” syndrome,” reveals Mattia Fogliacco, President of Sisvel International. “We are confident that LIFT will substantially help in fostering the creation of a level playing field,” he continues. Further information on LIFT can be found on Sisvel’s website [https://www.sisvel.com/licensing-programs/wireless-communications/wifi6/patent-pool/license-terms ] and blog [https://www.sisvel.com/blog/wireless-communications/lift-levelling-the-playing-field-for-early-licensees ].
“The patent pool will increase transparency of patent licensing and reduce licensing disputes in the field. Implementers can obtain a license under all patents in the pool at one time, which increases licensing efficiency and reduces licensing costs,” comments Alan Fan, Head of Huawei’s Intellectual Property Rights Department.
Steven Liu, Director at MediaTek states: “We support industry-driven licensing solutions that help to promote the adoption of new standards. We believe this group of industry participants, and with Sisvel as experienced administrator, can work together toward such goal.”
“Patent pools are the most efficient and transparent way to license Standard Essential Patents, reducing transaction costs and stimulating a level-playing field. For many years, Sisvel has been one of our partners in licensing audio/video codecs, and we are happy that we can now further expand our relationship into the Wi-Fi domain,” says Jako Eleveld, Head of IP Licensing at Royal Philips.
“SK Telecom is committed to always find the most efficient way to license its patents. We believe that this pool combines key patent owners, high quality assets and an innovative royalty scheme to align the interests of patent owners and implementors,” declares Hogeun Kim, Vice President of Corporate Legal Office at SK Telecom.
Wilus’ CEO, Jin Sam Kwak, explains that “Wilus endorses LIFT, the alternative scheme for sponsoring the adoption of this new technology for implementers. Adjusting royalty payments based on the global market penetration of Wi-Fi 6 licenses can incentivize adoption. With LIFT, the Wi-Fi 6 pool is made more attractive to potential licensees.”
Sisvel’s Wi-Fi Program Manager, Andrea Rombolà adds that “Licensing Wi-Fi technology has never been easy, but innovation has to be rewarded, because this is the only way to generate a virtuous circle to incentivize parties to innovate. Wi-Fi is such a key technology to our lives today, made ever so much more important by the pandemic and the associated work-from-home phenomena. This new pool represents a very efficient way to clear the rights of major owners of Wi-Fi 6 standard essential patents.” Mattia Fogliacco continues: “During the past two years of facilitation, we have created a framework that we feel will benefit the Markets for Technology as a whole, removing friction and aligning interests of innovators and implementers. We trust that this, together with the quality of the IP contributed by the participating patent owners, will quickly attract additional licensees and possibly additional patent owners.”
Sisvel is making the valuable portfolios included in the pool accessible on fair, reasonable, and non-discriminatory terms and conditions, by offering a royalty-bearing, non-transferable, non-assignable, non-exclusive license, with no right to grant sublicenses, under the participating patent owners’ patent portfolios essential to the 802.11ax specification.
Further information about the terms and conditions of this license offer is available on Sisvel’s website [https://www.sisvel.com/licensing-programs/wireless-communications/wifi6/patent-pool/introduction ]. For more details you may contact Sisvel at the following e-mail address WiFi6-Licensing@sisvel.com .
About Sisvel
Sisvel International S.A. is the holding company of the Sisvel Group. Sisvel is a world leader in fostering innovation and managing IP. The group identifies, evaluates and maximises the value of IP assets for its partners around the world, providing firms with a revenue stream which can be reinvested in innovation for the generation of future revenues. Sisvel has more than 40 years’ experience in the management of successful patent portfolios, including those relating to audio compression standards (MP3 and MPEG audio), as well as broadcasting and digital terrestrial television standards maintained by the Digital Video Broadcasting Project. Sisvel operates patent pools and joint licensing programmes in the fields of mobile communication, wireless local area networking 802.11, video coding, digital video broadcasting, recommendation engines and broadband access to data networks.
www.sisvel.com
View source version on businesswire.com: https://www.businesswire.com/news/home/20220719005183/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Incyte Announces Positive CHMP Opinion for Opzelura® (ruxolitinib) Cream for the Treatment of Adults with Moderate Atopic Dermatitis26.6.2026 13:30:00 CEST | Press release
If approved, Opzelura® (ruxolitinib) cream will be the first steroid-free, topical JAK treatment option in the European Union (EU) for adults with moderate atopic dermatitis (AD) for whom standard topical therapies have failedAD, the most common type of eczema which affects 230 million people globally,1 is a chronic, recurring, inflammatory and highly pruritic (itchy) skin condition that can have a significant impact on daily life2Phase 3 TRuE‑AD4 data supporting the positive CHMP opinion demonstrated that ruxolitinib cream met both co‑primary endpoints at Week 8, maintained disease control with as-needed treatment through Week 24 and was well tolerated3,4,5 Incyte (Nasdaq: INCY) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion recommending the approval of Opzelura® (ruxolitinib) cream for the treatment of moderate atopic dermatitis (AD) in adult patients for whom topical corticosteroids
Datroway® Recommended for Approval in the EU by CHMP as First-Line Treatment for Patients with Metastatic Triple Negative Breast Cancer Who Are Not Candidates for Immunotherapy26.6.2026 13:00:00 CEST | Press release
Recommendation based on TROPION-Breast02 phase 3 trial where Daiichi Sankyo and AstraZeneca’s Datroway showed a statistically significant and clinically meaningful improvement for the dual primary endpoints of overall survival and progression-free survival If approved, Datroway has potential to be the first TROP2 directed antibody drug conjugate for patients in EU with a demonstrated overall survival benefit as first-line treatment Datroway® (datopotamab deruxtecan) has been recommended for approval in the European Union (EU) as monotherapy for the first-line treatment of adult patients with unresectable or metastatic triple negative breast cancer (TNBC) who are not candidates for PD-1/PD-L1 inhibitor therapy. Datroway is a specifically engineered TROP2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use
DAYBU®(trofinetide) Recommended for Approval in the European Union by CHMP26.6.2026 12:49:00 CEST | Press release
-- European Commission decision expected in the coming months-- If approved, DAYBU®would become the first treatment for neurobehavioral symptoms of Rett syndrome in the European Union Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion following a re-examination procedure, recommending the granting of a marketing authorization for DAYBU® (trofinetide) for the treatment of neurobehavioral symptoms of Rett syndrome in adults and pediatric patients aged five years and older. If granted marketing authorization by the European Commission, DAYBU® would be the first therapy approved for this indication in the European Union (EU). “The CHMP’s positive opinion for DAYBU® is an important milestone in our mission to bring this innovative therapy to the EU, where there are no therapies specifically approved for the neurobehavioral symptoms of this devastating
HTEC Showcases Lakebase Branching at Databricks’ Data & AI Summit26.6.2026 11:18:00 CEST | Press release
HTEC, the global technology and AI engineering firm headquartered in Silicon Valley, last week showcased how it used Lakebase data branching to enable faster development, safer operations, and new possibilities for data-driven organizations operating in highly regulated environments. The Solution was developed in collaboration with a leading risk and compliance technology provider who serves financial institutions. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260626875859/en/ HTEC, the global technology and AI engineering firm headquartered in Silicon Valley, last week showcased how it used Lakebase data branching to enable faster development, safer operations, and new possibilities for data-driven organizations operating in highly regulated environments. Solving Critical Development Bottlenecks in Regulated Environments At the core of the collaboration was a shared challenge: how to enable modern data workflows in an envi
Stallergenes Greer Named One of Switzerland’s Best Managed Companies for 202626.6.2026 10:28:00 CEST | Press release
Stallergenes Greer, a global leader in allergy care, has been recognised for its overall business performance, company culture, and sustained growth by receiving the prestigious 2026 Switzerland’s Best Managed Companies award. The 2026 Best Managed Companies programme award winners are among Switzerland’s best private companies. The awards are derived from Deloitte’s global Best Managed Companies awards programme, an internationally recognised programme that evaluates businesses based on their leadership in the areas of strategy, culture and commitment, capabilities, innovation, governance and financial performance. Applicants are evaluated by an independent jury of experts. The evaluation of the Switzerland awards is based on more than 30 years of observed practice from the global awards programme that has been rolled out in 50+ countries worldwide. This recognition reflects Stallergenes Greer's consistent ability to deliver on its strategic vision while maintaining the operational di
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
